Search Results - David A. Power

Refine Results
  1. 1
    Nitric oxide in the kidney: functions and regulation of synthesis

    Nitric oxide in the kidney: functions and regulation of synthesis by Peter F. Mount, David A. Power

    Published 2006
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Heparanase Is Involved in the Pathogenesis of Proteinuria as a Result of Glomerulonephritis

    Heparanase Is Involved in the Pathogenesis of Proteinuria as a Result of Glomerulonephritis by Vicki Levidiotis, Craig Freeman, Chris Tikellis, Mark E. Cooper, David A. Power

    Published 2004
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Role of the energy sensor AMP-activated protein kinase in renal physiology and disease

    Role of the energy sensor AMP-activated protein kinase in renal physiology and disease by Kenneth R. Hallows, Peter F. Mount, Núria M. Pastor‐Soler, David A. Power

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Obesity-Related Chronic Kidney Disease—The Role of Lipid Metabolism

    Obesity-Related Chronic Kidney Disease—The Role of Lipid Metabolism by Peter F. Mount, Matthew Davies, Suet‐Wan Choy, Natasha Cook, David A. Power

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Unrecognized Anemia in Patients With Diabetes

    Unrecognized Anemia in Patients With Diabetes by Merlin C. Thomas, Richard J. MacIsaac, Con Tsalamandris, David A. Power, George Jerums

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin

    Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin by Mardiana Lee, Marina Katerelos, Kurt Gleich, Sandra Galić, Bruce E. Kemp, Peter F. Mount, David A. Power

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients

    AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients by Kévin Martin, Karen Pickthorn, Saling Huang, Geoffrey A. Block, Andrew Vick, Peter F. Mount, David A. Power, Gregory Bell

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction

    Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction by John Whitlam, Ling Ling, Alison Skene, John Kanellis, F. Ierino, Howard R. Slater, Damien L. Bruno, David A. Power

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius

    Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius by Philip A. Wescombe, Mathew Upton, Pierre Renault, Ruth E. Wirawan, David A. Power, Jeremy P. Burton, Chris N. Chilcott, John Tagg

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Regulation of the renal-specific Na+–K+–2Cl− co-transporter NKCC2 by AMP-activated protein kinase (AMPK)

    Regulation of the renal-specific Na+–K+–2Cl− co-transporter NKCC2 by AMP-activated protein kinase (AMPK) by Scott A. Fraser, Ignacio Gíménez, Natasha Cook, Ian G. Jennings, Marina Katerelos, Frosa Katsis, Vicki Levidiotis, Bruce E. Kemp, David A. Power

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes

    The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes by Katia Boven, Scott Stryker, John Knight, Adrian G. Thomas, Marc Van Regenmortel, D.M. Kemeny, David A. Power, Jérôme Rossert, Nicole Casadevall

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Fibrinogen Concentration and Risk of Ischemic Stroke and Acute Coronary Events in 5113 Patients With Transient Ischemic Attack and Minor Ischemic Stroke

    Fibrinogen Concentration and Risk of Ischemic Stroke and Acute Coronary Events in 5113 Patients With Transient Ischemic Attack and Minor Ischemic Stroke by Peter M. Rothwell, Sally C. Howard, David A. Power, Sergei A. Gutnikov, Ale Algra, J. van Gijn, Taane G. Clark, Michael Murphy, Charles Warlow

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods

    Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods by Richard J. MacIsaac, Con Tsalamandris, Merlin C. Thomas, Erosha Premaratne, Sianna Panagiotopoulos, T. J. Smith, Aurora Poon, Mark A. Jenkins, S Ratnaike, David A. Power, G. Jerums

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Pre-eclampsia is associated with altered expression of the renal sodium transporters NKCC2, NCC and ENaC in urinary extracellular vesicles

    Pre-eclampsia is associated with altered expression of the renal sodium transporters NKCC2, NCC and ENaC in urinary extracellular vesicles by Chih‐Chiang Hu, Marina Katerelos, Suet‐Wan Choy, Amy Crossthwaite, Susan Walker, Gabrielle Pell, Mardiana Lee, Natasha Cook, Peter F. Mount, Kathy Paizis, David A. Power

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Malignant spinal cord compression: NICE guidance, improvements and challenges

    Malignant spinal cord compression: NICE guidance, improvements and challenges by Philip Savage, Rachel Sharkey, Teresa Kua, Lyn Schofield, Devon Richardson, N. Panchmatia, Panagiotis Papanastasopoulos, Matthew Williams, Alison Falconer, David A. Power, Fiona J.L. Arnold, Christian Ulbricht

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    AMP‐activated protein kinase phosphorylation of endothelial NO synthase

    AMP‐activated protein kinase phosphorylation of endothelial NO synthase by Zhi-Ping Chen, Ken I. Mitchelhill, Belinda J. Michell, David Stapleton, Ignacio Rodrı́guez-Crespo, Lee A. Witters, David A. Power, Paul R. Ortiz de Montellano, Bruce E. Kemp

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Is Nonalbuminuric Renal Insufficiency in Type 2 Diabetes Related to an Increase in Intrarenal Vascular Disease?

    Is Nonalbuminuric Renal Insufficiency in Type 2 Diabetes Related to an Increase in Intrarenal Vascular Disease? by Richard J. MacIsaac, Sianna Panagiotopoulos, Karen J. McNeil, Trudy J. Smith, Con Tsalamandris, Huming Hao, P. G. Matthews, Merlin C. Thomas, David A. Power, George Jerums

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function

    Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function by Elif I. Ekinci, George Jerums, Alison Skene, Paul Crammer, David A. Power, Karey Cheong, Sianna Panagiotopoulos, Karen J. McNeil, Scott T. Baker, Paola Fioretto, Richard J. MacIsaac

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Vision-Threatening Retinal Abnormalities in Chronic Kidney Disease Stages 3 to 5

    Vision-Threatening Retinal Abnormalities in Chronic Kidney Disease Stages 3 to 5 by Rajeev Deva, Mohamad Afzal Alias, Deb Colville, Foong Kien Newk-Fon Hey Tow, Qi Lun Ooi, Sky Chew, Nor Fadhilah Mohamad, Anastasia Hutchinson, Ignatios Koukouras, David A. Power, Judy Savige

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive Pathways

    Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive Pathways by Jay C. Jha, Aozhi Dai, Jessica Garzarella, Amelia Charlton, Sofia Urner, Jakob Appel Østergaard, Jun Okabe, Chet E. Holterman, Alison Skene, David A. Power, Elif I. Ekinci, Melinda T. Coughlan, Harald Schmidt, Mark E. Cooper, Rhian M. Touyz, C. Kennedy, Karin Jandeleit‐Dahm

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: